Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy
Article in Frontiers in Pharmacology (January 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (January 2024)
Article in American Society of Clinical Oncology Educational Book (January 2024)
Article in Journal for ImmunoTherapy of Cancer (August 2023)